A rare case presentation of neurofibromatosis type 1 with multiple gastrointestinal stromal tumors: a case report


  • Aasit L. Pathak Department of General Surgery, Shri M.P. Shah Government Medical College, Jamnagar, Gujarat, India
  • G. V. Rajesh Department of General Surgery, Shri M.P. Shah Government Medical College, Jamnagar, Gujarat, India
  • Pankaj A. Chavda Department of General Surgery, Shri M.P. Shah Government Medical College, Jamnagar, Gujarat, India
  • Akshat K. Vadaliya Department of General Surgery, Shri M.P. Shah Government Medical College, Jamnagar, Gujarat, India
  • Jeemy S. Prajapati Department of General Surgery, Shri M.P. Shah Government Medical College, Jamnagar, Gujarat, India




Neurofibromatosis type 1, Gastrointestinal Stromal Tumours, NF1 gene


Neurofibromatosis type 1 (NF1), a hereditary cancer predisposing syndrome is an autosomal dominant disorder. Gastrointestinal stromal tumor (GIST) is the most prevalent non-neurological tumor in these individuals. In NF1-associated GIST, KIT and platelet-derived growth factor receptor α (PDGFRA) mutations might not be present, and Imatinib may not be effective. Surgical resection is the first-line treatment. The primary aim was to include the possibility of rare tumors including GIST in neurofibromatosis patients in the differential diagnosis of GIT pathology/presentation. A 50-year-old male with neurofibromatosis came with complaints of dull aching abdominal pain and on further investigation was found to have lesions in the distal small bowel, suspicious of nerve sheath tumors, in abdominal computed tomography. A laparotomy was performed and the jejunum containing nodular lesions was resected and pathologically diagnosed as GIST. The patient was then started on Imatinib. At the 6-month follow-up, no tumor recurrence was visible. The rare and unusual location of multiple GIST in neurofibromatosis patients underscores its importance in differential diagnosis, and our case report on the patient's therapy and the clinical outcome could aid in patient care.


Brems H, Beert E, de Ravel T, Legius E. Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009;10:508-15.

Parab TM, DeRogatis MJ, Boaz AM, Grasso SA, Issack PS, Duarte DA, et al. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019;10(1):144-54.

Neurofibromatosis Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575-8.

Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382:973-83.

Nishida T, Tsujimoto M, Takahashi T, Hirota S, Blay JY, Wataya-Kaneda M. Gastrointestinal stromal tumors in Japanese patients with neurofibromatosis type I. J Gastroenterol. 2016;51:571-8.

Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease) Am J Surg Pathol. 2005;29:755-63.

Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol. 2005;29:1170-6.

Bulusu VR, Casey R, Giger O, Carroll N, Maher E. Neurofibromatosis 1 (NF1) and gastrointestinal stromal tumors (GISTs): five-year experience from a regional center in United Kingdom. J Clin Oncol. 2019;37:11035.

Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006;30:90-6.

Salvi PF, Lorenzon L, Caterino S, Antolino L, Antonelli MS, Balducci G. Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases. Int J Surg Oncol. 2013;398570.

Gong J, Kang W, Zhu J, Xu J. CT and MR imaging of gastrointestinal stromal tumor of stomach: a pictorial review. Quant Imaging Med Surg. 2012;2:274-9.

Saleem TB, Ahmed I. Gastrointestinal stromal tumour--evolving concepts. Surgeon. 2009;7:36-41.

Espinosa I, Lee CH, Kim MK. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am J Surg Pathol. 2008;32:210-8.

Mandalà S, Lupo M, Guccione M, La Barbera C, Iadicola D, Mirabella A. Small bowel gastrointestinal stromal tumor presenting with gastrointestinal bleeding in patient with type 1 Neurofibromatosis: Management and laparoscopic treatment. Case report and review of the literature. Int J Surg Case Rep. 2021;79:84-90.

von Mehren M, Joensuu H. Gastrointestinal Stromal Tumors. J Clin Oncol. 2018;36:136-43.

Tian H, Wu XD, Ma Y, Jin SZ, Song SW. Multiple gastrointestinal stromal tumors of the small intestine with gastrointestinal bleeding: a case report. Zhonghua Putongwaike Zazhi. 2019;34:639.

Kim JJ, Lim JY, Nguyen SQ. Laparoscopic resection of gastrointestinal stromal tumors: Does laparoscopic surgery provide an adequate oncologic resection? World J Gastrointest Endosc. 2017;9:448-55.

Xu MM, Angeles A, Kahaleh M. Endoscopic full-thickness resection of gastric stromal tumor: one and done. Endoscopy. 2018;50:E42-3.






Case Reports